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Abstract: The triglyceride glucose (TyG) index, derived from a combination of fasting glucose and
triglycerides, has been suggested as a useful marker for insulin resistance (IR), in addition to modified
TyG indices that combine obesity parameters. This study investigated the association and utility
of TyG and modified TyG indices for IR prediction in youth. Based on the Korea National Health
and Nutritional Examination Survey, the data of 3728 youth aged 10–19 years were analyzed. Odds
ratios (ORs) and 95% confidence intervals (CIs) of tertiles 2 and 3 for each parameter were calculated
and compared with tertile 1 as a reference. To compare the parameters for identifying IR, receiver
operating characteristic curves were plotted and the area under the curve (AUC) was calculated. The
ORs and 95% CIs for insulin resistance (IR) progressively increased across tertiles of each parameter.
Overall, all modified TyG indices presented higher ORs and AUC than the TyG index. The TyG-body
mass index standard deviation score showed the largest AUC for IR detection in all subjects. In
conclusion, TyG and modified TyG indices could be used as valuable markers for the prediction of IR
in youth. Moreover, modified TyG indices had better diagnostic accuracy than the TyG index.
Keywords: triglycerides; glucose; insulin resistance; child; adolescent
1. Introduction
Insulin resistance (IR), characterized by an inadequate physiological response with
insensitivity to insulin, is a major risk factor for metabolic syndrome and cardiovascular
diseases (CVD) [1–3]. A systematic review revealed that the prevalence of metabolic
syndrome was high, at 3.3% in children and 29.2% in obese children [4]. Similarly, a
population-based study in Korea found that the prevalence of metabolic syndrome had
increased from 4.0% in 1998 to 7.8% in 2007 [5]. Considering the increasing prevalence of
metabolic syndrome in youth and association of metabolic syndrome with risk of type 2
diabetes and CVD, it is important to detect IR in children and adolescents [6].
For measuring IR, the glucose clamp technique is considered as the gold standard [7].
However, because of its complicated and invasive nature, this test is difficult to perform
in youth [8]. Therefore, homeostasis model assessment of insulin resistance (HOMA-IR)
index, calculated as the product of the fasting levels of glucose and insulin, is suggested as a
robust marker for IR quantification [1,9,10]. However, insulin measurement is not a routine
test in the clinical setting and has standardization problems [11]. Thus, various indices
combining glucose levels and lipid parameters were suggested as predictors of IR [12,13].
Among them, the triglyceride glucose (TyG) index, derived from the combination of fasting
glucose and triglycerides (TG), has been suggested as a useful marker for IR in adults [14].
In addition, modified TyG indices that combine obesity indices such as body mass
index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR) have been
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suggested because obesity is closely associated with IR [15,16]. Kim et al. [16] reported that
such modified TyG indices could act as alternative markers for assessing IR. Lee et al. [13]
reported that the TyG index combined with BMI or WC was superior to the TyG index
alone in among U.S population. However, investigations into the association between IR
and the TyG and modified TyG indices are extremely limited in youth.
Therefore, this study aimed to investigate the association of TyG and modified TyG
indices with IR in youth through the analysis of the Korean National Health and Nutrition
Examination Survey (KNHANES) data. The objectives of our study were (1) to compare the
TyG and modified TyG indices as surrogate markers for predicting IR and (2) to determine
valid cut-off values of the TyG and modified TyG indices for predicting IR.
2. Materials and Methods
2.1. Participants
This study included the data acquired in the third and fourth KNHANES, conducted
from 2007 to 2010. Figure 1 depicts the flowchart of study design and patient inclusion. KN-
HANES is a cross-sectional and nationally representative survey with a complex, stratified,
multistage probability sampling of the Korean population. It is conducted annually by the
Korea Centers for Disease Control and Prevention (KCDC) based on the National Health
Promotion and consists of health surveys, examinations, and nutrition surveys. These
data provide a variety of information about health status and behavior, socio-economic
demographics, and laboratory tests. Sample weights were used to account for differential
probabilities of selection and non-response and were included in the estimation process for
all analyses. The weighted data were then adjusted to represent the sex- and age-specific
Korean populations [17]. KNHANES is approved by the KCDC.
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Figure 1. Flowchart of the study population selection process. KNHANES, Korea National Health
and utrition Exa ination Survey.
2.2. Study Variables
Data on age, sex, anthropometric measurement, plasma lipid levels, and insulin
levels were collected. A portable stadiometer (range, 850–2060 mm; Seriter, Holtain Ltd.,
Crymych, UK) was used to the nearest 0.1 cm for height, and a calibrated balance beam
scale (Giant 150N; HANA, Seoul, Korea) was used in the upright position to the nearest
0.1 kg for weight. BMI was calculated as weight (kg)/height squared (m2). The height,
weight, and BMI were presented as standard deviation score (SDS) values on the basis
of the 2017 Korean National Growth Charts [18]. Children were classified as normal
weight (<85th percentile), overweight (85th–95th percentile), or obesity (≥95th percentile)
according to their BMI. WC was measured midway between the costal margin and iliac
crest at the end of a normal expiration, and WHtR was calculated as WC (cm)/height
(cm). Central obesity was defined as WC >90th percentile using the Korean waist reference
data [19].
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2.3. Laboratory Analysis
Blood samples were collected from an antecubital vein after an 8-h fast, processed,
and immediately refrigerated. The serum level of fasting glucose, total cholesterol (TC),
high-density lipoprotein cholesterol (HDL-C), and TG were measured using the Hitachi
7600 automatic analyzer (Hitachi, Tokyo, Japan). Serum insulin was measured using the
Wizard 1470 gamma counter (Perkin-Elmer, Turku, Finland).
Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald
formula (1) [20]:
LDL-C = TC − [HDL-C + (TG/5)] (1)
and non-HDL-C was calculated as TC − HDL-C [21]. The atherogenic index of plasma (AIP)
was defined as log (TG/HDL-C) [22]. For quantification of IR, HOMA-IR was calculated as
fasting insulin (mg/dL) × fasting glucose (mg/dL)/22.5. IR was defined as the HOMA-IR
of >95th percentile for each sex and age using Korean HOMA-IR reference data [16]. TyG
and modified TyG indices were defined and calculated as formula (2–6) [15,17]:
TyG index = Ln [TG (mg/dL) × fasting glucose (mg/dL)/2] (2)
TyG-BMI = TyG index × BMI (3)
TyG-BMI SDS = TyG index × BMI SDS (4)
TyG-WC = TyG index × WC (5)
TyG-WHtR = TyG index × WHtR (6)
2.4. Statistical Analysis
The sampling weights were considered in all analyses to report representative esti-
mates of the Korean children and adolescents. The data were analyzed using SAS, version
9.4 (SAS Inc., Cary, NC, USA), and R, version 4.0.2 (The R Foundation for Statistical Com-
puting, Vienna, Austria; http://www.R-project.org/; accessed on 8 August 2020), for the
complex survey design with clustering, stratification, and unequal weighting of the KN-
HANES sample. All continuous variables were expressed as weighted means with standard
errors, and categorical variables were expressed as numbers and weighted percentages.
The independent-samples t-test was used to compare continuous variables, and Pearson’s
chi-square test was used to compare categorical variables. Logistic regression analyses
were performed to explain the relationship between IR as the dependent variable and
various markers. ORs and 95% CIs of tertiles 2 and 3 for each parameter were calculated
and compared with tertile 1 as a reference. The correlation of TyG and modified TyG indices
with HOMA-IR was demonstrated using a scatter plot and adjusted line. Sensitivity and
specificity were calculated as the markers’ optimal cut-off values based on Youden’s index.
Receiver operating characteristic (ROC) curves were plotted, and the area under the curve
(AUC) was calculated to compare the relative diagnostic strengths of these parameters for
identifying IR. The bootstrap method was used to perform pairwise comparisons between
AUCs for the parameters. Significance was determined as p < 0.05.
3. Results
3.1. Baseline Characteristics of the Subjects
Table 1 shows the baseline characteristics of participants according to sex. The preva-
lence of IR was higher in males (13.19%) than in females (10.69%). WC, WHtR, glucose
level, and proportion of subjects with central obesity or IR were higher in males than in
females, while overall lipid levels were higher in females than in males. The TyG-BMI,
TyG-WC, and TyG-WHtR indices were higher in males than in females, while the TyG
index and TyG-BMI SDS were not significantly different between males and females.
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Table 1. Baseline characteristics of participants according to sex.
Total (n = 3728) Male (n = 1756) Female (n = 1972) p
Age (years) 14.56 (0.06) 14.53 (0.07) 14.60 (0.09) 0.476
Height (cm) 161.79 (0.23) 165.53 (0.33) 157.52 (0.22) <0.001
Height SDS 0.21 (0.02) 0.24 (0.03) 0.17 (0.03) 0.063
Weight (kg) 54.96 (0.29) 58.80 (0.42) 50.56 (033) <0.001
Weight SDS 0.03 (0.03) 0.07 (0.04) −0.02 (0.04) 0.056
BMI (kg/m2) 20.73 (0.07) 21.17 (0.10) 20.23 (0.11) <0.001
BMI SDS −0.09 (0.03) −0.06 (0.04) −0.13 (0.04) 0.225
WC (cm) 70.11 (0.21) 72.42 (0.29) 67.48 (0.27) <0.001
WC > 90p 16.45% (0.75) 14.75% (0.98) 18.40% (1.18) 0.020
WHtR 0.43 (0.01) 0.44 (0.02) 0.43 (0.02) <0.001
Glucose (mg/dL) 88.82 (0.19) 89.32 (0.25) 88.24 (0.20) <0.001
Insulin (µIU/mL) 13.62 (0.18) 13.53 (0.25) 13.71 (0.23) 0.574
HOMA-IR 3.04 (0.05) 3.05 (0.08) 3.03 (0.06) 0.834
IR * 12.03% (0.68) 13.19% (0.90) 10.69% (0.93) 0.044
TC (mg/dL) 158.25 (0.58) 154.59 (0.81) 162.44 (0.74) <0.001
LDL-C (mg/dL) 91.23 (0.50) 88.96 (0.69) 93.82 (0.65) <0.001
Non-HDL-C (mg/dL) 108.65 (0.56) 106.35 (0.78) 111.28 (0.73) <0.001
TG (mg/dL) 88.55 (1.16) 88.60 (1.62) 88.50 (1.50) 0.962
HDL-C (mg/dL) 49.61 (0.20) 48.25 (0.25) 51.16 (0.28) <0.001
AIP 0.46 (0.01) 0.48 (0.02) 0.441 (0.02) 0.083
TyG index 8.14 (0.01) 8.14 (0.02) 8.14 (0.01) 0.650
TyG-BMI 169.17 (0.69) 172.89 (0.99) 164.91 (0.95) <0.001
TyG-BMI SDS −0.58 (0.22) −0.277 (0.30) −0.931 (0.32) 0.140
TyG-WC 571.93 (2.05) 591.16 (2.93) 549.94 (2.47) <0.001
TyG-WHtR 3.54 (0.01) 3.57 (0.02) 3.49 (0.02) 0.003
Values are presented as mean (standard error), and categorical data as percentages (standard error). * IR was
defined as the HOMA-IR of >95th percentile for each sex and age. SDS, standard deviation score; BMI, body
mass index; WC, waist circumference; WHtR, waist-to-height ratio; HOMA-IR, homeostasis model assessment of
insulin resistance; IR, insulin resistance; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C,
high-density lipoprotein cholesterol; TG, triglycerides; AIP, atherogenic index of plasma; TyG, triglyceride glucose
index.
3.2. ORs of TyG and Modified TyG Indices for Predicting IR
The ORs and 95% CIs for IR progressively increased across tertiles of each parameter
(Table 2). All TyG and modified TyG indices exhibited significantly higher ORs and 95%
CIs of tertile 3 (OR range 6.06–14.66) than that of tertile 1 (all p < 0.001) in the total subjects.
In contrast, the lipid parameters exhibited ORs of tertile ranged as 0.43–4.25 compared with
those of tertile 1 in the total subjects. Among the modified indices, TyG-WHtR presented
the highest ORs and 95% CIs for IR in the total subjects (OR = 14.66) and males (OR = 21.59)
while TyG-BMI SDS presented the highest ORs and 95% CIs in females (OR = 8.78). Overall,
all modified TyG indices presented higher ORs and 95% CIs than TyG index and lipid
profiles in the subjects.
Table 2. Odds ratio for insulin resistance according to tertiles of each parameter.
Total Male Female
OR (95% Cl) p OR (95% Cl) p OR (95% Cl) p
TC (mg/dL)
T2 1.10 (0.82–1.49) 0.133 1.38 (0.90–2.10) 0.515 0.73 (0.46–1.14) 0.066
T3 1.75 (1.30–2.36) <0.001 2.36 (1.61–3.47) <0.001 1.09 (0.72–1.65) 0.175
LDL-C (mg/dL)
T2 0.83 (0.62–1.11) 0.010 1.16 (0.79–1.71) 0.317 0.61 (0.39–0.93) 0.018
T3 1.34 (1.00–1.80) 0.003 1.88 (1.26–2.78) 0.001 0.94 (0.62–1.44) 0.329
Non-HDL-C (mg/dL)
T2 1.02 (0.75–1.40) 0.004 1.12 (0.74–1.68) 0.005 0.73 (0.44–1.19) 0.027
T3 2.26 (1.66–3.08) <0.001 3.28 (2.19–4.89) <0.001 1.34 (0.89–2.14) 0.012
TG (mg/dL)
T2 1.96 (1.35–2.84) 0.706 2.65 (1.63–4.30) 0.925 1.28 (0.76–2.14) 0.340
T3 4.25 (2.99–6.05) <0.001 6.78 (4.23–10.88) <0.001 2.45 (1.56–3.86) <0.001
HDL-C (mg/dL)
T2 0.61 (0.47–0.79) 0.544 0.63 (0.45–0.89) 0.764 0.38 (0.25–0.58) 0.004
T3 0.43 (0.32–0.59) <0.001 0.44 (0.29–0.67) 0.003 0.45 (0.30–0.68) 0.114
AIP
T2 1.82 (1.26–2.63) 0.565 2.66 (1.65–4.27) 0.693 1.27 (0.77–2.30) 0.385
T3 3.90 (2.78–5.46) <0.001 6.14 (3.88–9.72) <0.001 2.33 (1.48–3.66) <0.001
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Table 2. Cont.
Total Male Female
OR (95% Cl) p OR (95% Cl) p OR (95% Cl) p
TyG index
T2 2.77 (1.84–4.16) 0.427 3.28 (1.92–5.56) 0.596 1.90 (1.09–3.30) 0.857
T3 6.06 (4.13–8.89) <0.001 8.76 (5.228–14.667) <0.001 3.34 (2.05–5.45) <0.001
TyG-BMI
T2 2.21 (1.35–3.62) 0.013 2.75 (1.32–5.71) 0.048 2.02 (1.08–3.80) 0.240
T3 11.43 (7.11–18.36) <0.001 20.59 (10.45–40.56) <0.001 7.17 (4.10–12.55) <0.001
TyG-BMI SDS
T2 3.53 (2.03–6.16) 0.831 3.438 (1.661–7.119) 0.330 3.580 (1.771–7.235) 0.430
T3 13.50 (7.84–23.25) <0.001 19.05 (9.43–38.50) <0.001 8.78 (4.58–16.83) <0.001
TyG-WC
T2 1.732 (1.109–2.707) <0.001 2.476 (1.285–4.772) 0.023 1.92 (1.08–3.40) 0.286
T3 9.10 (5.92–13.99) <0.001 17.44 (9.38–32.42) <0.001 5.90 (3.47–10.05) <0.001
TyG-WHtR
T2 2.45 (1.42–4.22) 0.018 2.72 (1.27–5.79) 0.048 1.93 (1.03–3.63) 0.090
T3 14.66 (8.88–24.21) <0.001 21.59 (11.15–41.80) <0.001 8.25 (4.62–14.73) <0.001
ORs and 95% CIs of tertiles 2–3 for each parameter were calculated and compared with those of tertile 1 as a
reference. OR, odds ratio; CI, confidence interval; T, tertile; TC, total cholesterol; LDL-C, low-density lipoprotein
cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; AIP, atherogenic index of plasma;
TyG, triglyceride glucose index; BMI, body mass index; SDS, standard deviation score; WC, waist circumference;
WHtR, waist-to-height ratio.
3.3. Correlation of TyG and Modified TyG Indices with HOMA-IR
In scatter plot and fitted line of TyG and modified TyG indices with HOMA-IR, HOMA-
IR tended to increase with increasing TyG and modifed TyG indices (all p < 0.001) (Figure 2).
Among the indices, coefficient of correlation was highest in TyG-WHtR (r = 0.405, p < 0.001).
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3.4. Cut-off Values and AUC of the TyG and Modified TyG Indices for Predicting IR
The result of RO curve an lyses and AUCs with the corresponding 95% CIs for
TyG and modified TyG indices re shown in Table 3 and Figure 3. AUC ranged from 0.723
to 0.810 in total subjects. All TyG a d modified TyG indices p edicted IR significantly
(all p < 0.001). In total subjects, the cut-off values for IR pre iction were 8.261, 178.957,
5.105, 599.800, and 3.696 in TyG index, TyG-BMI, TyG-BMI SDS, TyG-WC, and TyG-WHtR,
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respectively (all p < 0.001). TyG-BMI SDS showed the largest AUC for IR detection with
0.810 in total subjects and 0.766 in females (p < 0.001), respectively. In males, TyG-BMI and
TyG-WHtR showed the largest AUC with 0.842 for IR detection (p < 0.001). Overall, all
modified TyG indices—TyG-BMI, TyG-BMI SDS, TyG-WC, and TyG-WHtR—presented
significantly higher AUC and 95% CIs than the TyG index (Table A1). Among the modified
TyG indices, TyG-BMI and TyG-BMI SDS presented significantly higher AUC and 95% CIs
than TyG-WC in the total subjects. In addition, TyG-WHtR presented significantly higher
AUC and 95% CIs than TyG-WC overall (total subjects, p < 0.001; males, p = 0.002; females,
p = 0.034).
Table 3. Cut-off values and areas under the receiver operating characteristic curves for each parameter
for predicting insulin resistance.
Cut-off Sensitivity Specificity AUC 95% Cl p
Total
TyG index 8.261 66.449 65.555 0.723 (0.699–0.748) <0.001
TyG-BMI 178.957 72.331 76.201 0.807 (0.785–0.829) <0.001
TyG-BMI SDS 5.105 68.445 79.450 0.810 (0.788–0.831) <0.001
TyG-WC 599.800 71.678 75.834 0.786 (0.763–0.810) <0.001
TyG-WHtR 3.696 74.728 75.436 0.809 (0.788–0.831) <0.001
Male
TyG index 8.175 76.604 60.457 0.756 (0.726–0.786) <0.001
TyG-BMI 184.058 79.245 77.680 0.842 (0.817–0.867) <0.001
TyG-BMI SDS 5.137 76.190 78.274 0.838 (0.811–0.865) <0.001
TyG-WC 600.847 83.019 70.299 0.820 (0.792–0.848) <0.001
TyG-WHtR 3.719 81.132 75.220 0.842 (0.817–0.868) <0.001
Female
TyG index 8.260 64.433 63.508 0.680 (0.639–0.721) <0.001
TyG-BMI 172.931 67.010 73.367 0.757 (0.720–0.794) <0.001
TyG-BMI SDS 4.883 58.101 80.623 0.766 (0.730–0.802) <0.001
TyG-WC 616.650 51.031 87.452 0.744 (0.705–0.783) <0.001
TyG-WHtR 3.588 72.680 70.551 0.761 (0.725–0.797) <0.001
AUC, area under the curve; TyG, triglyceride glucose index; BMI, body mass index; SDS, standard deviation
score; WC, waist circumference; WHtR, waist-to-height ratio.
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TyG- HtR 3.696 74.728 75.436 0.809 (0.788–0.831) < 0.001 
Male       
TyG index 8.175 76.604 60.457 0.756 (0.726–0.786) < 0.001 
TyG-BMI 184.058 79.245 77.680 0.842 (0.817–0.867) < 0.001 
TyG-BMI SDS 5.137 76.190 78.274 .838 (0.811–0.865) < .001 
TyG-WC 600.847 83.019 70.299 0.820 (0.792–0.848) < 001 
TyG- HtR 3.719 81.132 75.220 0.842 (0.817–0.868) < 0.001 
Female       
TyG index 8.260 64.433 63.508 0.680 (0.639–0.721) < 0.001 
TyG-BMI 172.931 67.010 73.367 0.757 (0.720–0.794) < 0.001 
TyG-BMI SDS 4.883 58.101 80.623 0.766 (0.730–0.802) < 0.001 
TyG-WC 616.650 51.031 87.452 0.744 (0.705–0.783) < 0.001 
TyG-WHtR 3.588 72.680 70.551 0.761 (0.725–0.797) < 0.001 
AUC, area under the curve; TyG, triglyceride glucose index; BMI, body mass index; SDS, standard 
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Figure 3. Receiver operating characteristic curve for each parameter in the prediction of insulin 
resistance. (a) ROC curve of the prediction of insulin resistance in all subjects. (b) ROC curve of 

















































Figure 3. Receiver operating characteristic curve for each parameter in the prediction of insulin
resistance. (a) ROC curve of the prediction of insulin resistance in all subjects. (b) ROC curve of
the prediction of insulin resistance in males. (c) ROC curve of the prediction of insulin resistance in
females. ROC: receiver operating characteristic; TyG index, triglyceride glucose index; BMI, body
mass index; SDS, standard deviation score; WC, waist circumference; WHtR, waist-to-height ratio.
4. Discussion
This study shows that the TyG and modified TyG indices can be important predictors
for IR in youth. The ORs and 95% CIs for IR progressively increased across tertiles of
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each parameter, and the TyG and modified TyG indices predicted IR significantly in the
ROC curve analysis. Overall, modified TyG indices presented higher ORs and 95% CIs
for predicting IR than the TyG index and lipid profiles. Among all indices, TyG-WHtR
showed the strongest association with HOMA-IR, and TyG-BMI SDS was the most powerful
predictor for IR in total subjects. In addition, TyG-WHtR was superior to TyG-WC for
predicting IR in the present study.
IR plays an important role in type 2 diabetes, metabolic syndrome, and CVD [23].
Therefore, early detection of IR in people at risk for future CVD is important. Among the
detection methods, TyG and modified TyG indices have been proposed as reliable markers
in adults [16,24,25]. A population-based cross-sectional study suggested that the TyG index
is useful for IR prediction in adults [26]. Another longitudinal study reported that the TyG
index predicts type 2 diabetes in middle-aged and older adults [27]. However, elaborate
studies that investigated the relationship between the TyG and modified TyG indices in
youth are extremely limited.
Several studies have validated the relationship between the TyG index and IR. First, hy-
pertriglyceridemia may increase hepatic glucose output with the increased transport of free
fatty acids to the liver, making it one of the important risk factors for type 2 diabetes [28,29].
Research has shown that TG elevation can induce IR through the impairment of muscle
glucose metabolism [30]. Second, insulin accelerates adipocyte TG stores by promoting TG
synthesis and inhibiting lipolysis as well as promoting the maturation of adipocytes [28].
In addition, insulin stimulates lipoprotein lipase activity, thus increasing the uptake of fatty
acids from circulating lipoproteins.
Obesity is strongly associated with IR [16]. Therefore, a combination of the TyG index
and obesity parameters may predict IR better than the TyG index alone. Because BMI is
a simple and widely used indicator of obesity and other metabolic risks, TyG-BMI can
be a useful predictive marker [25]. Lim et al. [16] reported that TyG-BMI was superior to
other modified TyG indices for predicting IR in adults. In children, obesity is defined as a
BMI of ≥95th percentile of sex- and age-specific references; thus, BMI SDS should be used
more commonly than BMI itself [31]. Therefore, we suggested a new parameter, TyG-BMI
SDS, to explain obesity better than TyG-BMI in youth. It exhibited the largest AUC for the
prediction of IR among all parameters in total subjects and females.
Measures of central obesity, such as WC and WHtR, have been suggested as better
indices than BMI because central obesity is closely associated with fat distribution but not
BMI [32]. A meta-analysis revealed that measures of central obesity predict cardiovascular
risk factors, including diabetes, hypertension, and dyslipidemia better than BMI [33]. A
systematic review reported that combining BMI with measures of central obesity is superior
to using BMI alone to assess the mortality risk of patients with coronary artery disease [34].
Among the measures of central obesity, WC does not directly reflect the difference in height,
and age-dependent WC cutoffs are required [35]. However, WHtR has been reported
to outperform WC and BMI in predicting metabolic syndrome and cardiovascular risks
accounting for height, especially in Asians [36]. Overweight children with a higher WHtR
are more likely to have higher cardiometabolic risk factors [32,37]. Thus, we analyzed both
TyG-WHtR and TyG-WC and found TyG-WHtR to be superior to TyG-WC in predicting IR
in youth. In contrast, TyG-WC was superior to TyG-WHtR in an adult study [16].
High-carbohydrate diet increases insulin level, which raises TG synthesis and glucose
level [28,29,38]. Thus, response to dietary carbohydrate restriction might provide an oper-
ational definition of metabolic syndrome [38]. Carbohydrate restriction is considered as
effective nutritional therapy for metabolic syndrome [39–41]. Thus, the ability of carbohy-
drate restriction and ketogenic diets to control the markers of the metabolic syndrome has
been suggested [42,43]. Our study investigated association of the TyG and modified TyG
indices with IR in the population with cross-sectional data. Further studies investigating
improvement in the TyG and modified TyG indices after dietary carbohydrate restriction
and ketogenic diet could make these parameters even more robust.
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This study has some limitations. First, this was a cross-sectional study exclusive to
Korean youth, thus limiting the generalizability of our findings. Second, associated factors,
such as pubertal status, diet, and physical activity, were not considered. Third, lean and
fat body mass were not considered in this study. Despite these limitations, the present
study assessed the TyG and modified TyG indices as markers of IR across a large number
of children and adolescents. In addition, we proposed a new parameter, TyG-BMI SDS, as
one of the important predictors of IR in youth.
5. Conclusions
This study indicates that the TyG and modified TyG indices could serve as valuable
predictors of IR in youth. Moreover, combinations of obesity parameters with the TyG
index—including the new parameter, TyG-BMI SDS—have better diagnostic accuracy than
the TyG index. The TyG and modified TyG indices are simple and cost-effective markers of
IR. Thus, these markers are useful for the assessment of cardiometabolic risk factors.
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Appendix A
Table A1. Comparison of areas under receiver operating curves among each parameters for predicting
insulin resistance.
TyG index TyG-BMI TyG-BMI SDS TyG-WC TyG-WHtR
Total
TyG index reference <0.001 <0.001 <0.001 <0.001
TyG-BMI <0.001 reference 0.617 <0.001 0.739
TyG-BMI SDS <0.001 0.617 reference 0.011 >0.999
TyG-WC <0.001 <0.001 0.011 reference <0.001
TyG-WHtR <0.001 0.739 >0.999 <0.001 reference
Male
TyG index reference <0.001 <0.001 <0.001 <0.001
TyG-BMI <0.001 reference 0.505 <0.001 >0.999
TyG-BMI SDS <0.001 0.505 reference 0.046 0.617
TyG-WC <0.001 <0.001 0.046 reference 0.002
TyG-WHtR <0.001 >0.999 0.617 0.002 reference
Female
TyG index reference <0.001 <0.001 <0.001 <0.001
TyG-BMI <0.001 reference 0.413 0.149 0.739
TyG-BMI SDS <0.001 0.413 reference 0.143 0.721
TyG-WC <0.001 0.149 0.143 reference 0.034
TyG-WHtR <0.001 0.739 0.721 0.034 reference
Bootstrap method was used to perform pairwise comparisons between AUCs for the parameters. Values are
presented as p values. TyG, triglyceride glucose index; BMI, body mass index; SDS, standard deviation score; WC,
waist circumference; WHtR, waist-to-height ratio; AUC, area under the curve.
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